Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesigercept in Chronic Spontaneous Urticaria (CLEAR)
NCT07415551Phase 2Recruiting
- Sponsor
- Yuhan
- Start
- Mar 2026
- Primary completion
- Jun 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 4
01
Overview
A Phase 2 trial of YH35324 in chronic spontaneous urticaria (CSU), sponsored by Yuhan. Started Mar 2026; status: recruiting.
02
Drugs
YH35324
03
Conditions
chronic spontaneous urticaria (CSU)
Beyond the preview
Go deeper on NCT07415551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07415551.